Home › NCT06434337

Evaluation of a Novel Point-of-Care Diagnostic Test for Human Papillomavirus (HPV)

Who can join

Ages 21 and older · Women

Inclusion Criteria:

1. People with a cervix 21 years of age or older.
2. Scheduled to undergo hrHPV testing at MD Anderson and The Harris Health System (LBJ Hospital) according to national and institutional guidelines at time of enrollment OR are anticipated to undergo a LEEP, ECC, or biopsy.
3. Willing and able to provide informed consent.
4. Able to perform protocol-required activities. Able to speak and read English or Spanish.

Exclusion Criteria

1. Patient or provider decision not to perform HPV testing. This does not apply to patients that are undergoing either a LEEP, ECC or biopsy.
2. Participant or provider decision not to collect a sample for this study.
3. Participants that are pregnant.

About the study

To learn if new HPV tests can provide the same results as standard HPV tests. The findings from this study may aid in the development of new HPV tests that require less equipment and are more accessible.

What is being tested

• Novel point-of-care diagnostic test for detecting HPV ("Rice HPV test") (diagnostic test)

Sponsor: M.D. Anderson Cancer Center · Participants: 600 · Started: Jul 23, 2024

Contact the study team

• Kathleen Schmeler, MD · Phone: (713) 745-3518

Official record on ClinicalTrials.gov — NCT06434337

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.